HBIO · trading date Oct 13, 2026 · previous close $8.20 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$86.55M
Net income
-$56.70M
Total assets
$80.07M
Total liabilities
$66.34M
Stockholders' equity
$13.73M
Cash & equivalents
$8.61M
Operating income
-$48.58M
Operating cash flow
$6.73M
Capital expenditures
$1.26M
Fiscal year 2025, via 10-K filed 2026-03-13.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-56.1%
Net margin
-65.5%
Free cash flow
$5.47M
Free cash flow margin
6.3%
Liabilities / assets
82.8%
Equity / assets
17.2%
CapEx / revenue
1.5%
Operating cash flow / net income
-0.12×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Holliston, MA 01746
84 OCTOBER HILL RD
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:33 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.